How To Use Mysimba Tablets

Mysimba (naltrexone/bupropion) is a prescription medication for weight loss in adults with obesity. Contains 8mg naltrexone and 90mg bupropion per tablet.

Key Takeaways

  • Dosing: 4-week escalation to maintenance dose (2 tablets twice daily)
  • Administration: Swallow whole with water - do not crush/chew
  • Timing: Morning and evening doses (avoid evening dose if insomnia occurs)
  • Discontinuation: Gradual tapering recommended
  • Effectiveness: Assess after 16 weeks - discontinue if <5% weight loss

Mysimba provides effective weight management through a carefully controlled dosing schedule designed to minimize side effects while maximizing effectiveness.

Mysimba Dosage Schedule

1

Week 1: Initial Dose

1 tablet in morning for first 7 days

2

Week 2: Increased Frequency

1 tablet morning and evening for next 7 days

3

Week 3: Further Increase

2 tablets morning and 1 tablet evening for next 7 days

4

Week 4: Maintenance Dose

2 tablets twice daily (maximum 2 tablets per dose, 4 tablets daily)

Important: This gradual escalation helps minimise side effects. Do not exceed maximum daily dose of 4 tablets (32mg naltrexone/360mg bupropion).

Warning: Never suddenly stop Mysimba - reduce dose gradually over 1-2 weeks to avoid withdrawal symptoms (e.g., irritability, anxiety).

How To Take Mysimba Tablets

Correct Administration

  • Swallow tablets whole with water
  • Take with food to reduce nausea
  • Morning dose: With breakfast
  • Evening dose: Before 6pm (to prevent insomnia)
  • Space doses at least 8 hours apart

Avoid These Common Mistakes

Mistake Risk Correct Approach
Crushing/chewing tablets Rapid release causing side effects Swallow whole
Taking with high-fat meal Increased bupropion absorption Take with light meal
Late evening dose Insomnia Take before 6pm

Important Precautions

Do NOT take Mysimba if you have:
  • Uncontrolled hypertension
  • Seizure disorder
  • Eating disorder (bulimia/anorexia)
  • Severe liver cirrhosis
  • Concurrent use of monoamine oxidase inhibitors (MAOIs)

Monitoring Requirements

  • Blood pressure: Check weekly for first 3 months
  • Weight: Assess after 16 weeks - discontinue if <5% loss
  • Mental health: Monitor for mood changes/suicidal thoughts

Missed Dose Instructions

Situation Action
Missed morning dose Take as soon as remembered if <8hrs until evening dose
Missed evening dose Skip and resume next morning
Missed ≥2 doses Restart at previous tolerated dose

Never double dose to make up for a missed tablet - this increases seizure risk.

FAQs

Avoid alcohol - it lowers seizure threshold and increases dizziness risk. The NHS recommends no more than 1-2 units occasionally, spaced away from doses.

The modified-release coating controls drug absorption. Crushing causes rapid release, potentially leading to seizures (bupropion) or severe nausea (naltrexone).

NICE guidelines recommend discontinuation as you're unlikely to achieve clinically meaningful weight loss. Your doctor will suggest alternative therapies.

No - bupropion passes into breast milk. The MHRA advises against breastfeeding during and for 7 days after treatment.

Keep in original packaging at room temperature (below 25°C). The desiccant packet in the bottle should remain - it prevents moisture damage to the tablets.

Ready to Start Your Weight Loss Journey?

If you're struggling to lose weight through diet and exercise alone, our UK-registered doctors can help determine if Mysimba Tablets is appropriate for your condition through a confidential online consultation.

Secure Prescription & Next-Day Delivery

MHRA-compliant | GPhC-registered pharmacy | Discreet packaging

Start UTI Consultation
Medical Content Manager
Authored by Nabeel

Medical Content Manager

Nabeel is a co-founder and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Talal is a GMC registered doctor and medical reviewer at Chemist Doctor. He ensures clinical accuracy and reliability across health content.

Medical Director
Approved by Usman

Medical Director

Usman is a co-founder and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.

Review Date: 18 November 2025

Next Review: 20 May 2026

Published on: 18 November 2025

Last Updated: 19 November 2025

We Are Regulated
GPhc RegisteredRegistered PharmacyGMC Registered
RPS MemberCannabis Industry memberMCCS member
LegitScript CertifiedDMCA protectedICO registered
NMCNMC
real idvisamastercardamexmaestroRoyal MailRoyal Mail